LAGE3 promotes cell metastasis and stemness in non-small cell lung cancer companied with AKT/PI3K signaling pathway activation

被引:0
|
作者
Zhang, Heng [1 ,2 ]
Jian, Junling [1 ]
Chen, Hai [1 ]
Zhu, Xiaodong [1 ]
Xie, Jianfeng [1 ]
Xu, Xianquan [1 ]
机构
[1] Anhui Chest Hosp, Dept Thorac Surg, Hefei 230031, Anhui, Peoples R China
[2] Anhui Chest Hosp, Dept Thorac Surg, 397 Jixi Rd, Hefei 230022, Anhui, Peoples R China
关键词
NSCLC; LAGE3; AKT/PI3K; Cell proliferation; Migration and invasion; Stemness; EXPRESSION; DIAGNOSIS;
D O I
10.1016/j.prp.2023.154700
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Background: Non-small cell lung cancer (NSCLC) is reported to have high mortality and morbidity rate worldwide. It is highly susceptible to metastasis. Previous reports have shown the L antigen family member 3 (LAGE3) expression in many cancers and has a carcinogenic role. However, the molecular mechanism of LAGE3 in NSCLC needs to be further explored.Methods: LAGE3 expression profile of NSCLC patients and normal samples in the TCGA cohort was utilized for visualization. Expression pattern of LAGE3 in cell lines of NSCLCs were determined through qRT-PCR. Further, transfection experiments was conducted to measure the LAGE3 & PRIME;s effect on the migration, proliferation, invasion, and stemness in NSCLC cell lines (A549 and H1975) by the assays of CCK-8, colony formation, EdU, transwell, and flow cytometry. The in vivo xenograft tumor growth in the nude mouse was conducted to confirm LAGE3 effect on NSCLC tumor growth. Furthermore, western blotting was applied to determine the levels of core proteins including AKT/PI3K signaling pathway and stemness proteins of Nanog, OCT4 and SOX2.Results: The TCGA based computational analysis showed that LAGE3 mRNA level in NSCLC was inter-related to worse overall survival. The up-regulated level of LAGE3 in NSCLC cell lines indicated its possibility as a future diagnostic and prognostic biomarker. Functional assays showed that cell migration, proliferation, invasion, sphere formation, and stemness-related protein (Nanog, SOX2, and OCT4) levels were significantly repressed by the knockdown of LAGE3. Subsequently, inhibition of LAGE3 in nude mice (in vivo) demonstrated its ability to reduce the tumor growth of NSCLC. The study also showed that LAGE3 knockdown suppressed cell progression by inactivating the signaling pathway of AKT/PI3K. Conclusions: LAGE3 could promote NSCLC development by activating the AKT/PI3K signaling pathway, thereby accelerating metastasis and cell stemness.
引用
收藏
页数:13
相关论文
共 50 条
  • [21] PAQR3 inhibits proliferation via suppressing PI3K/AKT signaling pathway in non-small cell lung cancer
    Li, Xiaohui
    Li, Mengfei
    Chen, Dong
    Shi, Gongning
    Zhao, Hui
    ARCHIVES OF MEDICAL SCIENCE, 2018, 14 (06) : 1289 - 1297
  • [22] Targeting PI3K/AKT/mTOR pathway in non small cell lung cancer
    Fumarola, Claudia
    Bonelli, Mara A.
    Petronini, Pier Giorgio
    Alfieri, Roberta R.
    BIOCHEMICAL PHARMACOLOGY, 2014, 90 (03) : 197 - 207
  • [23] Lentinan mitigates pemetrexed chemoresistance by the PI3K/Akt pathway in non-small cell lung cancer
    Tian, Ping
    Du, Dajun
    Yang, Li
    Zhou, Nan
    Tao, Ling
    CELL BIOCHEMISTRY AND BIOPHYSICS, 2024, 82 (02) : 1421 - 1431
  • [24] MET exon 14 skipping mutation promotes metastasis via activation of the PI3K/Akt-Rac1 pathway in non-small cell lung cancer
    Wang, Feng
    Shum, Elaine
    Perez-Soler, Roman
    Cheng, Haiying
    Halmos, Balazs
    CANCER RESEARCH, 2019, 79 (13)
  • [25] PI3K/AKT inhibition induces compensatory activation of the MET/STAT3 pathway in non-small cell lung cancer
    Bian, Chunan
    Liu, Zonghang
    Li, Dakou
    Zhen, Lifeng
    ONCOLOGY LETTERS, 2018, 15 (06) : 9655 - 9662
  • [26] Activation of M3 muscarinic receptor by acetylcholine promotes non-small cell lung cancer cell proliferation and invasion via EGFR/PI3K/AKT pathway
    Xu, Ran
    Shang, Chao
    Zhao, Jungang
    Han, Yun
    Liu, Jun
    Chen, Kuanbing
    Shi, Wenjun
    TUMOR BIOLOGY, 2015, 36 (06) : 4091 - 4100
  • [27] GPX2 promotes EMT and metastasis in non-small cell lung cancer by activating PI3K/AKT/mTOR/Snail signaling axis
    Peng, Fang
    Xu, Qiushi
    Jing, Xiaomeng
    Chi, Xinming
    Zhang, Zheming
    Meng, Xiangpeng
    Liu, Xinyuan
    Yan, Jiao
    Liu, Xuefeng
    Shao, Shujuan
    FASEB BIOADVANCES, 2023, 5 (06) : 233 - 250
  • [28] Reduced PDCD4 Expression Promotes Cell Growth Through PI3K/Akt Signaling in Non-Small Cell Lung Cancer
    Zhen, Yan
    Li, Dongming
    Li, Wen
    Yao, Weimin
    Wu, Aibing
    Huang, Jing
    Gu, Hongli
    Huang, Yujie
    Wang, Yajun
    Wu, Jun
    Chen, Min
    Wu, Dong
    Lyu, Quanchao
    Fang, Weiyi
    Wu, Bin
    ONCOLOGY RESEARCH, 2015, 23 (1-2) : 61 - 68
  • [29] PI3K/AKT Signaling Pathway in the Regulation of Non-small Cell Lung Cancer Radiosensitivity After Hypofractionated Radiation Therapy
    Wang, P.
    Liu, N.
    Pang, Q.
    Qu, C.
    Wang, B.
    Guo, H.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012, 84 (03): : S670 - S670
  • [30] Fucoxanthin Inactivates the PI3K/Akt Signaling Pathway to Mediate Malignant Biological Behaviors of Non-Small Cell Lung Cancer
    Fang, Xuehong
    Zhu, Yuzhen
    Zhang, Taomin
    Li, Qian
    Fan, Lvhua
    Li, Xiaodan
    Jiang, Daishun
    Lin, Jie
    Zou, Liyi
    Ren, Jianwei
    Huang, Zunnan
    Ye, Hua
    Liu, Yi
    NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL, 2022, 74 (10): : 3747 - 3760